World Health Organisation(WHO). WHO coronavirus disease(covid-19) dashboard. Geneva: World Health Organisation; 2022. [Link]

World Health Organisation(WHO). The different types of covid-19 vaccines. Geneva: World Health Organisation; 2022. [Link]

World Health Organisation(WHO). Side effects of covid-19 vaccines. Geneva: World Health Organisation; 2022. [Link]

Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, et al. Safety and efficacy of an rad26 and rad5 vector-based heterologous prime-boost covid-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. 2021; 397(10275):671-81. [DOI:10.1016/S0140-6736(21)00234-8] [PMID] [PMCID]

Pagotto V, Ferloni A, Mercedes Soriano M, Díaz M, Braguinsky Golde N, González MI, et al. Active monitoring of early safety of sputnik v vaccine in Buenos Aires, Argentina. Medicina(B Aires). 2021; 81(3):408-14. [PMID]

Jarynowski A, Semenov A, Kamiński M, Belik V. Mild adverse events of sputnik v vaccine in Russia: Social media content analysis of telegram via deep learning. Journal of Medical Internet Research. 2021; 23(11):e30529. [DOI:10.2196/30529] [PMID] [PMCID]

Zare H, Rezapour H, Mahmoodzadeh S, Fereidouni M. Prevalence of covid-19 vaccines(sputnik v, azd-1222, and covaxin) side effects among healthcare workers in Birjand city, Iran. International Immunopharmacology. 2021; 101(Pt B):108351. [DOI:10.1016/j.intimp.2021.108351] [PMID] [PMCID]

Montalti M, Soldà G, Di Valerio Z, Salussolia A, Lenzi J, Forcellini M, et al. Rocca Observational study: Early results on safety of sputnik v vaccine(gam-covid-vac) in the Republic of San Marino using active surveillance. EClinicalMedicine. 2021; 38:101027. [DOI:10.1016/j.eclinm.2021.101027] [PMID] [PMCID]

Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored covid-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet. 2020; 395(10240):1845-54. [DOI:10.1016/S0140-6736(20)31208-3]

Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G, et al. Side effects and Immunogenicity following administration of the Sputnik v covid-19 vaccine in health care workers in Iran. Scientific Reports. 2021; 11(1):21464. [DOI:10.1038/s41598-021-00963-7] [PMID] [PMCID]

Houshmand B, Keyhan SO, Fallahi HR, Ramezanzade S, Sadeghi E, Yousefi P. Vaccine-associated complications: A comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in sars cov ii, gam-covid-vac(sputnik v), chadox1 ncov-19(astrazeneca), bbv152(covaxin), or bbibp-corv(sinopharm)? Maxillofacial Plastic and Reconstructive Surgery. 2022; 44(1):3. [DOI:10.1186/s40902-021-00330-6] [PMID] [PMCID]

Sun Q, Fathy R, McMahon DE, Freeman EE. Covid-19 vaccines and the skin: The landscape of cutaneous vaccine reactions worldwide. Dermatologic Clinics. 2021; 39(4):653-73. [DOI:10.1016/j.det.2021.05.016] [PMID] [PMCID]